ADC Therapeutics S.A. (ADCT) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    ADC Therapeutics S.A.

    NYSE: ADCT · Real-Time Price · USD
    3.40
    0.11 (3.34%)
    At close: Sep 04, 2025, 3:59 PM
    3.40
    -0.16%
    After-hours: Sep 04, 2025, 06:22 PM EDT

    ADC Therapeutics S.A. Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 70.84M 69.56M 209.91M 33.92M
    Cost of Revenue
    		 5.95M 2.53M 4.58M 1.39M
    Gross Profit
    		 64.89M 67.03M 205.33M 32.52M
    Operating Income
    		 -130.65M -165.99M -123.63M -261.72M
    Interest Income
    		 12.27M 10.54M 2.57M 66K
    Pretax Income
    		 -156.14M -195.42M -154.66M -251.5M
    Net Income
    		 -157.85M -240.05M -155.8M -230.03M
    Selling & General & Admin
    		 85.91M 105.89M 143.49M 136.24M
    Research & Development
    		 109.63M 127.13M 187.9M 158M
    Other Expenses
    		 -3.28M n/a n/a n/a
    Operating Expenses
    		 192.27M 233.01M 328.96M 294.24M
    Interest Expense
    		 50.21M 46.33M 36.73M 18.34M
    Selling & Marketing Expenses
    		 21.44M 57.46M 35.75M 64.78M
    Cost & Expenses
    		 201.49M 235.54M 333.54M 295.64M
    Income Tax Expense
    		 166K 39.11M 1.14M -21.48M
    Shares Outstanding (Basic)
    		 97.16M 81.71M 78.15M 76.75M
    Shares Outstanding (Diluted)
    		 97.16M 81.71M 78.15M 76.75M
    EPS (Basic)
    		 -1.62 -2.94 -1.99 -3
    EPS (Diluted)
    		 -1.62 -2.94 -1.99 -3
    EBITDA
    		 -103.71M -146.76M -108.06M -223.72M
    EBIT
    		 -106.99M -150.03M -110.09M -233.16M
    Depreciation & Amortization
    		 3.28M 3.27M 2.39M 2.63M

    Add to Watchlist